Agios Pharma (AGIO) Stock Statistics & Valuation Metrics

Agios Pharma has a market cap or net worth of $2.19B. The enterprise value is $1.04B.

Agios Pharma has 58,101,517 shares outstanding. The number of shares has decreased by -2.65% in one year.

Agios Pharma’s return on equity (ROE) is 0.44 and return on invested capital (ROIC) is -24.99%.

The current PE Ratio of Agios Pharma is 3.4. Agios Pharma’s PEG ratio is -0.00964.

In the last 12 months, Agios Pharma had revenue of 36.50M and earned 673.73M in profits. Earnings per share was 11.86.

In the last 12 months, operating cash flow was -406.00M and capital expenditures -3.03M, giving a free cash flow of -409.02M billion.

Agios Pharma pays an annual dividend of ―, resulting in a dividend yield of ―

Agios Pharma upcoming earnings date is Oct 30, 2025, TBA (Confirmed).

Agios Pharma as a current ratio of 11.90, with Debt / Equity ratio of 3.56%

In the past 12 months, Agios Pharma has paid 44.24M in taxes.

Agios Pharma EV to EBITDA ratio is -4.34, with an EV/FCF ratio of -4.72.

Agios Pharma has $938.94M in cash and marketable securities with $48.76M in debt, giving a net cash position of -$890.18M billion.

Gross margin is 88.18%, with operating margin of -1166.47%, and net profit margin of 1845.92%.

The average price target for Agios Pharma is $55.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy